The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding and predicting fatigue, cardiovascular (CV) decline, and events after breast cancer treatment (UPBEAT): A prospective cardio-oncology study.
 
Kerryn Reding
No Relationships to Disclose
 
Ralph D'Agostino
Consulting or Advisory Role - cardioxyl; Coherus Biosciences; Edwards Lifesciences; Exelixis; Novartis; Puma Biotechnology; RedHill Biopharma; Sandoz; Sanofi; Target Health; Teva
 
Glenn Jay Lesser
Honoraria - BTG; Monteris Medical
Consulting or Advisory Role - Cancer Expert Now; Stemline Therapeutics
Research Funding - ImmunoCellular Therapeutics; Incyte; Newlink Genetics; Novartis; Pfizer; Vascular Biogenics
 
Heidi D. Klepin
Consulting or Advisory Role - Genentech
Patents, Royalties, Other Intellectual Property - UptoDate contributor
 
Lynne I. Wagner
Consulting or Advisory Role - Celgene; EveryFit; Janssen
 
Dalane Kitzman
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Abbvie; Akros; AstraZeneca; Bayer; Boehringer Ingelheim; CinRx Pharma; Corvia Medical; Duke Clinical Research Institute; Merck; Novartis; Relypsa; St. Luke's Hospital
Research Funding - AstraZeneca; Bayer; Novartis
 
Peter H. Brubaker
No Relationships to Disclose
 
Shannon Mihalko
No Relationships to Disclose
 
Jennifer Jordan
No Relationships to Disclose
 
Nancy E. Avis
No Relationships to Disclose
 
Karen Marie Winkfield
Consulting or Advisory Role - Novartis
 
Bonnie Ky
Consulting or Advisory Role - Bioinvent; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Mateon Therapeutics; Roche; Roche
Research Funding - Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Have a patent on the use of neuregulin-1b as a biomarker in heart failure; Pending patent application on the use of IgE as a biomarker of cardiotoxicity
 
Susan Faye Dent
Honoraria - amgen; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; novartis; Pfizer; Roche Canada
 
Teresa Crotts
No Relationships to Disclose
 
Tonya Calhoun
No Relationships to Disclose
 
Kimberly Lane
No Relationships to Disclose
 
W. Gregory Hundley
No Relationships to Disclose